Published in Gut on May 01, 1991
Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol (1992) 3.97
Characterization and presumptive identification of Helicobacter pylori isolates from rhesus monkeys. J Clin Microbiol (1994) 1.39
Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut (1997) 1.22
Effect of biopsies on sensitivity and specificity of ultra-rapid urease test for detection of Helicobacter pylori infection: a prospective evaluation. World J Gastroenterol (2004) 0.99
Use of Romanowsky type (Diff-3) stain for detecting Helicobacter pylori in smears and tissue sections. J Clin Pathol (1992) 0.94
Imprint cytology--a cheap, rapid and effective method for diagnosing Helicobacter pylori. Postgrad Med J (1993) 0.89
Improving management of duodenal ulcer disease. Postgrad Med J (1997) 0.88
Histology compared with chemical testing for urease for rapid detection of Helicobacter pylori in gastric biopsy specimens. J Clin Pathol (1993) 0.86
Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma. Gastric Cancer (2006) 0.82
Analysis of p53, K-ras gene mutation & Helicobacter pylori infection in patients with gastric cancer & peptic ulcer disease at a tertiary care hospital in north India. Indian J Med Res (2012) 0.79
One-day high-dose combined therapy of Helicobacter pylori infection. Dig Dis Sci (1997) 0.79
Expression of parathyroid hormone related peptide in human pituitary tumours. J Clin Pathol (1993) 0.77
Herpes simplex virus type 1 in peptic ulcer disease: an inverse association with Helicobacter pylori. World J Gastroenterol (2005) 0.76
One minute unbuffered urease test: should it be read at 10 minutes? Gut (2000) 0.75
Ultrarapid urease test. Gut (1992) 0.75
Evaluation of the one-minute ultra-rapid urease test for diagnosing Helicobacter pylori. Postgrad Med J (1999) 0.75
Campylobacter enteritis: a "new" disease. Br Med J (1977) 34.77
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (1984) 32.58
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (1983) 23.90
Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust (1985) 8.49
Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet (1984) 7.45
Characterization of urease from Campylobacter pylori. J Clin Microbiol (1988) 5.57
Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02
Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol (1987) 4.70
Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut (1986) 4.47
Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa. J Infect Dis (1987) 3.69
A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66
Campylobacter pyloridis gastritis I: Detection of urease as a marker of bacterial colonization and gastritis. Am J Gastroenterol (1987) 3.65
Rapid diagnosis of Campylobacter-associated gastritis. Lancet (1985) 3.38
Acridine-orange to identify Campylobacter pyloridis in formalin fixed, paraffin-embedded gastric biopsies. Lancet (1986) 3.08
Carbon-14 urea breath test for the diagnosis of Campylobacter pylori associated gastritis. J Nucl Med (1988) 2.80
Campylobacter pylori urease: a new serological test. Lancet (1988) 2.78
14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68
Immune response to Campylobacter pyloridis in patients with peptic ulceration. Lancet (1985) 2.64
Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy. J Clin Pathol (1986) 2.38
Urease tests for Campylobacter pylori: care in interpretation. J Clin Pathol (1988) 2.35
Rapid diagnosis of Campylobacter pyloridis infection. Lancet (1986) 2.03
Colonization of gastric lesions by urease-positive bacteria. Am J Clin Pathol (1988) 1.98
Detection of Campylobacter pylori by the biopsy urease test: an assessment in 1445 patients. Gut (1989) 1.91
14C-urea breath test in C pylori gastritis. Gut (1989) 1.89
Simple half-gram stain for showing presence of Campylobacter pyloridis in sections. J Clin Pathol (1987) 1.84
Rapid diagnosis of Campylobacter pyloridis infection. J Clin Pathol (1987) 1.74
Histological identification of Campylobacter using Gimenez technique in gastric antral mucosa. J Clin Pathol (1987) 1.72
Monoclonal antibodies for specific immunoperoxidase detection of Campylobacter pylori. Gastroenterology (1989) 1.72
Isolation from gastric epithelium of Campylobacter-like bacteria that are distinct from "Campylobacter pyloridis". Lancet (1985) 1.69
One-minute endoscopy room test for Campylobacter pylori. Lancet (1988) 1.64
Four hour rapid urease test (RUT) for detecting Campylobacter pylori: is it reliable enough to start treatment? J Clin Pathol (1988) 1.53
Cresyl fast violet staining method for Campylobacter like organisms. J Clin Pathol (1987) 1.41
Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin. Gastroenterology (1988) 1.19
Comparison of different tests for Campylobacter pylori. Scand J Gastroenterol Suppl (1988) 1.16
Improved visualisation of mucus penetration by Campylobacter pylori using a Brown-Hopps stain. J Clin Pathol (1988) 0.90
Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea. Lancet (1994) 4.23
Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol (1992) 3.97
Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies. Lancet (1984) 2.87
Molecular cloning and expression of Campylobacter pylori species-specific antigens in Escherichia coli K-12. Infect Immun (1989) 2.81
The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients. J Infect Dis (1986) 2.61
Jejunal efflux in short bowel syndrome. Lancet (1990) 2.52
Nucleotide sequence of two genes from Helicobacter pylori encoding for urease subunits. Nucleic Acids Res (1990) 2.38
Bile-salt deconjugation and steatorrhoea in patients with the stagnant-loop syndrome. Lancet (1968) 2.36
Detection of pathogenic Yersinia enterocolitica by the polymerase chain reaction. Lancet (1990) 2.23
Restorative proctocolectomy with ileal reservoir: a pathophysiological assessment. Gut (1981) 2.21
Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.07
Diagnosis of giardiasis by specific IgM antibody enzyme-linked immunosorbent assay. Lancet (1986) 2.04
Jejunal bacteriology and bile-salt metabolism in patients with intestinal malabsorption. Lancet (1966) 2.03
Immunoblot analysis of the serological response in systemic candidosis. Lancet (1984) 1.90
Isolation of Clostridium difficile from patients and the environment of hospital wards. J Clin Pathol (1983) 1.89
Sensibility of the rectum to distension and the anorectal distension reflex in ulcerative colitis. Gut (1978) 1.87
Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology (1997) 1.86
Crucial role for 5-HT in cholera toxin but not Escherichia coli heat-labile enterotoxin-intestinal secretion in rats. Gastroenterology (1998) 1.85
Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin. MAbs (2010) 1.83
Inflammation in ileal reservoirs: 'pouchitis'. Gut (1990) 1.80
10 Years of infective endocarditis at St. Bartholomew's Hospital: analysis of clinical features and treatment in relation to prognosis and mortality. Lancet (1980) 1.78
Dilutional diarrhoea: under-diagnosed and over-investigated. Eur J Gastroenterol Hepatol (2000) 1.75
Bacteria, bile, and the small bowel. Gut (1969) 1.74
Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile. J Clin Microbiol (1986) 1.73
Escherichia coli antibodies in patients with inflammatory bowel disease. Gut (1978) 1.73
Low gluten diet in the treatment of adult coeliac disease: effect on jejunal morphology and serum anti-gluten antibodies. Gut (1988) 1.70
Intestinal transit in anxiety and depression. Gut (1996) 1.67
Research misconduct. Gut (1997) 1.67
One-minute endoscopy room test for Campylobacter pylori. Lancet (1988) 1.64
Method for the typing of Clostridium difficile based on polyacrylamide gel electrophoresis of [35S]methionine-labeled proteins. J Clin Microbiol (1986) 1.64
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut (1998) 1.62
Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol (1987) 1.58
Genetic analysis of a tetracycline resistance element from Clostridium difficile and its conjugal transfer to and from Bacillus subtilis. J Gen Microbiol (1990) 1.57
Travellers' diarrhoea. BMJ (1993) 1.57
H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3. Oncogene (2010) 1.56
Retractions in Gut 10 years after publication. Gut (2001) 1.49
A group II intron in a conjugative transposon from the gram-positive bacterium, Clostridium difficile. Gene (1996) 1.47
Diagnostic and therapeutic efficacy of barium meal examination: a prospective evaluation in general practice. BMJ (1989) 1.46
Campylobacter species in male homosexuals. Br J Vener Dis (1979) 1.45
The clinical importance of gram-positive anaerobic cocci isolated at St Bartholomew's Hospital, London, in 1987. J Med Microbiol (1994) 1.44
Characterization of a plasmid from Helicobacter pylori encoding a replication protein common to plasmids in gram-positive bacteria. Mol Microbiol (1991) 1.43
The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterology (2000) 1.43
Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect (2001) 1.42
A selective enrichment broth for the isolation of Clostridium difficile. J Clin Pathol (1984) 1.41
Relationship of toxin production to species in the genus Aeromonas. J Med Microbiol (1986) 1.41
Irritable bowel syndrome. QJM (1995) 1.40
Association between production of toxins A and B and types of Clostridium difficile. J Clin Pathol (1987) 1.38
Preliminary findings of the international typing study on Clostridium difficile. International Clostridium Difficile Study Group. Clin Infect Dis (1997) 1.37
A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res (1998) 1.36
Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology (1990) 1.35
The pathophysiological role of small intestinal bacterial flora. Scand J Gastroenterol Suppl (1970) 1.35
The use of rats associated with a human faecal flora as a model for studying the effects of diet on the human gut microflora. J Appl Bacteriol (1987) 1.35
Restriction endonuclease DNA analysis of Clostridium difficile. J Clin Microbiol (1987) 1.33
Mammalian bile promotes growth of Giardia lamblia in axenic culture. Trans R Soc Trop Med Hyg (1983) 1.33
Serum-bile-acids in the stagnant-loop syndrome. Lancet (1969) 1.30
K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology (1997) 1.29
Rapid diagnosis of Bacteroides infections by indirect immunofluorescence assay of clinical specimens. Lancet (1979) 1.29
Cimetidine in the prevention of gastric ulcer relapse. Postgrad Med J (1979) 1.29
Selective affective biasing in recognition memory in the irritable bowel syndrome. Gut (1993) 1.28
Description and characterization of a surface lectin from Giardia lamblia. Infect Immun (1986) 1.28
Toxin production by Aeromonas spp. from different sources. J Med Microbiol (1986) 1.28
Water and solute absorption from a new hypotonic oral rehydration solution: evaluation in human and animal perfusion models. Gut (1992) 1.26
Rapid fingerprinting of Helicobacter pylori by polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol (1993) 1.26
Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. J Assoc Physicians India (2005) 1.26
Water, electrolyte, glucose, and glycine absorption in rat small intestinal transplants. Gastroenterology (1988) 1.24
Molecular cloning and expression of Clostridium difficile toxin A in Escherichia coli K12. FEBS Lett (1987) 1.22
Detection and identification of Helicobacter pylori by the polymerase chain reaction. J Clin Pathol (1991) 1.22
Antigenic cross-reactivity and functional inhibition by antibodies to Clostridium difficile toxin A, Streptococcus mutans glucan-binding protein, and a synthetic peptide. Infect Immun (1991) 1.21
Transfer of macrolide-lincosamide-streptogramin B (MLS) resistance in Clostridium difficile is linked to a gene homologous with toxin A and is mediated by a conjugative transposon, Tn5398. J Antimicrob Chemother (1995) 1.21
Natural history of Giardia infection of infants and children in rural Guatemala and its impact on physical growth. Am J Clin Nutr (1986) 1.20
Promotion of gallbladder emptying by intravenous aminoacids. Lancet (1993) 1.19
Clostridium difficile and cytotoxin in routine faecal specimens. J Clin Pathol (1982) 1.19
Attachment of Giardia lamblia to rat intestinal epithelial cells. Gut (1988) 1.18
Efficacy of oral rehydration solutions in a rat model of secretory diarrhea. J Pediatr Gastroenterol Nutr (1988) 1.17
Determination of individual bile acids in biological fluids by thin-layer chromatography and fluorimetry. J Clin Pathol (1970) 1.17
Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut (1992) 1.16
Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology (2001) 1.16
Octreotide in the treatment of intestinal lymphangiectasia. Eur J Gastroenterol Hepatol (1998) 1.15
Serological studies of Bacteroides fragilis. J Hyg (Lond) (1977) 1.15
Rapid identification of toxigenic Clostridium difficile by polymerase chain reaction. Lancet (1990) 1.15
5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut (1994) 1.15
Molecular cloning and genetic analysis of a chloramphenicol acetyltransferase determinant from Clostridium difficile. Antimicrob Agents Chemother (1988) 1.14
The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut (1998) 1.13
Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut (2000) 1.13
Characterization of Helicobacter pylori PldA, a phospholipase with a role in colonization of the gastric mucosa. Gastroenterology (1999) 1.12
Immunoblot analysis of serological responses in invasive aspergillosis. J Clin Pathol (1985) 1.12
Attachment of Giardia lamblia trophozoites to a cultured human intestinal cell line. Gut (1995) 1.11
Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther (1994) 1.11
Mucosal-associated bacterial flora of the intestine in patients with Crohn's disease and in a control group. Gut (1978) 1.11
Tonsil surface and core cultures in recurrent tonsillitis: prevalence of anaerobes and beta-lactamase producing organisms. Eur J Clin Microbiol Infect Dis (1994) 1.11
Functional analysis of the roles of FliQ and FlhB in flagellar expression in Helicobacter pylori. FEMS Microbiol Lett (1999) 1.10
Relationship of the intestinal bacterial flora to absorption. Br Med Bull (1967) 1.10
Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans. J Clin Pathol (1985) 1.10
Screening for asymptomatic colorectal cancer. BMJ (1997) 1.10
Effects of bile and bile salts on growth and membrane lipid uptake by Giardia lamblia. Possible implications for pathogenesis of intestinal disease. J Clin Invest (1985) 1.10
Tropical enteropathy: a T-cell-mediated crypt hyperplastic enteropathy. Eur J Gastroenterol Hepatol (2001) 1.10
Effect of bicarbonate, acetate, and citrate on water and sodium movement in normal and cholera toxin-treated rat small intestine. Scand J Gastroenterol (1989) 1.09